|
CYB5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89143999999031E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.617400E-04 |
| Normal-vs-Stage2 |
9.384100E-02 |
| Normal-vs-Stage3 |
3.48760000001835E-06 |
| Normal-vs-Stage4 |
1.22809999947293E-07 |
| Stage1-vs-Stage2 |
3.566800E-01 |
| Stage1-vs-Stage3 |
4.137800E-02 |
| Stage1-vs-Stage4 |
3.055200E-03 |
| Stage2-vs-Stage3 |
4.722500E-02 |
| Stage2-vs-Stage4 |
5.358900E-03 |
| Stage3-vs-Stage4 |
2.514600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13759999999819E-05 |
| Normal-vs-AfricanAmerican |
4.274300E-02 |
| Normal-vs-Asian |
1.526340E-02 |
| Caucasian-vs-AfricanAmerican |
4.821600E-01 |
| Caucasian-vs-Asian |
2.377600E-01 |
| AfricanAmerican-vs-Asian |
8.820800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.14170000000436E-05 |
| Normal-vs-Female |
7.69059999999877E-05 |
| Male-vs-Female |
2.125800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.523800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.03390000000003E-05 |
| Normal-vs-Age(61-80Yrs) |
1.037380E-04 |
| Normal-vs-Age(81-100Yrs) |
3.882100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.797800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.516420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.179200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.122200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.066000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.148600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.897400E-01 |
| Classical-VS-Follicular |
9.286000E-01 |
| Classical-VS-Other |
4.613000E-01 |
| Classical-VS-Normal |
7.438700E-04 |
| Tall-VS-Follicular |
3.139200E-01 |
| Tall-VS-Other |
9.497800E-01 |
| Tall-VS-Normal |
3.389900E-04 |
| Follicular-VS-Other |
5.540400E-01 |
| Follicular-VS-Normal |
3.762300E-03 |
| Other-VS-Normal |
2.556000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.359360E-04 |
| Normal-vs-N1 |
2.23880000005394E-06 |
| N0-vs-N1 |
2.782400E-02 |
|
|
